Literature DB >> 32909979

Optical Coherence Tomography Neuro-Toolbox for the Diagnosis and Management of Papilledema, Optic Disc Edema, and Pseudopapilledema.

Patrick A Sibony1, Mark J Kupersmith, Randy H Kardon.   

Abstract

BACKGROUND: Distinguishing optic disc edema from pseudopapilledema is a common, sometimes challenging clinical problem. Advances in spectral-domain optical coherence tomography (SD-OCT) of the optic nerve head (ONH) has proven to be a cost effective, noninvasive, outpatient procedure that may help. At its core are tools that quantify the thickness of the retinal nerve fiber layer (RNFL) and ganglion cell-inner plexiform layer (GC-IPL). The SD-OCT also provides a set of tools that may be qualitatively interpreted in the same way that we read an MRI. They include the transverse axial, en face, and circular tomogram. Our goal is to describe a practical office-based set of tools using SD-OCT in the diagnosis and monitoring of papilledema, optic disc edema, and pseudopapilledema. EVIDENCE ACQUISITION: Searches on PubMed were performed using combinations of the following key words: OCT, papilledema, pseudopapilledema, optic disc drusen, retinal folds (RF), and choroidal folds (CF).
RESULTS: The principal elements of SD-OCT analysis of the ONH are the RNFL and GC-IPL thickness; however, these metrics have limitations when swelling is severe. Qualitative interpretation of the transverse axial SD-OCT aids in assessing peripapillary shape that may help distinguish papilledema from pseudopapilledema, evaluate atypical optic neuropathies, diagnose shunt failures, and identify outer RF and CF. There is a consensus that the SD-OCT is the most sensitive way of identifying buried optic disc drusen. En face SD-OCT is especially effective at detecting peripapillary wrinkles and outer retinal creases, both of which are common and distinctive signs of optic disc edema that rule out pseudopapilledema. Mechanically stressing the ONH in the adducted eye position, in patients with papilledema, may expose folds and peripapillary deformations that may not be evident in primary position. We also discuss how to optimize the acquisition and registration of SD-OCT images.
CONCLUSIONS: The SD-OCT is not a substitute for a complete history and a careful examination. It is, however, a convenient ancillary test that aids in the diagnosis and management of papilledema, optic disc edema, and pseudopapilledema. It is particularly helpful in monitoring changes over the course of time and distinguishing low-grade papilledema from buried drusen. The application of the SD-OCT toolbox depends on optimizing the acquisition of images, understanding its limitations, recognizing common artifacts, and accurately interpreting images in the context of both history and clinical findings.
Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the North American Neuro-Opthalmology Society.

Entities:  

Mesh:

Year:  2021        PMID: 32909979      PMCID: PMC7882012          DOI: 10.1097/WNO.0000000000001078

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   4.415


  99 in total

1.  A comparison of imaging techniques for diagnosing drusen of the optic nerve head.

Authors:  M M Kurz-Levin; K Landau
Journal:  Arch Ophthalmol       Date:  1999-08

2.  Change in Optic Nerve After Intracranial Pressure Reduction in Children.

Authors:  Won June Lee; Hae Jin Kim; Ki Ho Park; Yong Woo Kim; Michael J A Girard; Jean Martial Mari; Seung-Ki Kim; Ji Hoon Phi; Jin Wook Jeoung
Journal:  Ophthalmology       Date:  2017-06-16       Impact factor: 12.079

3.  Peripapillary Hyperreflective Ovoid Mass-Like Structures: Is It Optic Disc Drusen or Not?

Authors:  Kyoung Min Lee; Se Joon Woo; Jeong-Min Hwang
Journal:  J Neuroophthalmol       Date:  2018-12       Impact factor: 3.042

4.  Optic nerve head drusen and pseudotumor cerebri.

Authors:  B Katz; P Van Patten; J F Rothrock; R Katzman
Journal:  Arch Neurol       Date:  1988-01

5.  Lamina cribrosa displacement after optic nerve sheath fenestration in idiopathic intracranial hypertension: a new tool for monitoring changes in intracranial pressure?

Authors:  Marta Perez-Lopez; Darren S J Ting; Lucy Clarke
Journal:  Br J Ophthalmol       Date:  2014-08-12       Impact factor: 4.638

6.  Retinal ganglion cell layer thickness and local visual field sensitivity in glaucoma.

Authors:  Ali S Raza; Jungsuk Cho; Carlos G V de Moraes; Min Wang; Xian Zhang; Randy H Kardon; Jeffrey M Liebmann; Robert Ritch; Donald C Hood
Journal:  Arch Ophthalmol       Date:  2011-12

Review 7.  Optical coherence tomography in papilledema: what am I missing?

Authors:  Randy Kardon
Journal:  J Neuroophthalmol       Date:  2014-09       Impact factor: 3.042

8.  Detection and quantification of retinal nerve fiber layer thickness in optic disc edema using stratus OCT.

Authors:  Giacomo Savini; Costantino Bellusci; Michele Carbonelli; Maurizio Zanini; Valerio Carelli; Alfredo A Sadun; Piero Barboni
Journal:  Arch Ophthalmol       Date:  2006-08

9.  Choroidal folds associated with increased intracranial pressure.

Authors:  S R Griebel; G S Kosmorsky
Journal:  Am J Ophthalmol       Date:  2000-04       Impact factor: 5.258

10.  Follow-up of mild papilledema in idiopathic intracranial hypertension with optical coherence tomography.

Authors:  Gema Rebolleda; Francisco J Muñoz-Negrete
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-11-14       Impact factor: 4.799

View more
  2 in total

1.  Macular and Optic Disc Parameters in Children with Amblyopic and Nonamblyopic Eyes under Optical Coherence Tomography Fundus Images.

Authors:  Dan Zhu; Qiang Sun; Hong Yang; Yangcheng Zou; Chunmei Liu; Yan Xu
Journal:  Comput Math Methods Med       Date:  2022-06-15       Impact factor: 2.809

2.  Peripapillary Hyper-reflective Ovoid Mass-like Structure (PHOMS): An Optical Coherence Tomography Marker of Axoplasmic Stasis in the Optic Nerve Head.

Authors:  J Alexander Fraser; Patrick A Sibony; Axel Petzold; Caroline Thaung; Steffen Hamann
Journal:  J Neuroophthalmol       Date:  2021-12-01       Impact factor: 4.415

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.